Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study

Stefania Chiappini, Giovanni Martinotti

Research output: Contribution to journalArticlepeer-review

1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study'. Together they form a unique fingerprint.

Medicine & Life Sciences